David A Drew1, Daniel E Weiner1, Hocine Tighiouart2, Tammy Scott3, Kristina Lou1, Amy Kantor1, Li Fan1, James A Strom4, Ajay K Singh5, Mark J Sarnak6. 1. Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, MA. 2. The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA; Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA. 3. Department of Psychiatry, Tufts Medical Center, Boston, MA. 4. Saint Elizabeth's Medical Center, Boston, MA. 5. Division of Nephrology, Brigham and Women's Hospital, Boston, MA. 6. Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, MA. Electronic address: msarnak@tuftsmedicalcenter.org.
Abstract
BACKGROUND: Cognitive impairment is common in hemodialysis patients and is associated with significant morbidity. Limited information exists about whether cognitive impairment is associated with survival and whether the type of cognitive impairment is important. STUDY DESIGN: Longitudinal cohort. SETTING & PARTICIPANTS: Cognitive function was assessed at baseline and yearly using a comprehensive battery of cognitive tests in 292 prevalent hemodialysis patients. PREDICTOR: Using principal component analysis, individual test results were reduced into 2 domain scores, representing memory and executive function. By definition, each score carried a mean of 0 and SD of 1. OUTCOMES: Association of each score with all-cause mortality was assessed using Cox proportional hazards models adjusted for demographics and dialysis and cardiovascular (CV) risk factors. RESULTS: Mean age of participants was 63 years, 53% were men, 23% were African American, and 90% had at least a high school education. During a median follow-up of 2.1 (IQR, 1.1-3.7) years, 145 deaths occurred. Each 1-SD better executive function score was associated with a 35% lower hazard of mortality (HR, 0.65; 95% CI, 0.55-0.76). In models adjusting for demographics and dialysis-related factors, this relationship was partially attenuated but remained significant (HR, 0.81; 95% CI, 0.67-0.98), whereas adjustment for CV disease and heart failure resulted in further attenuation (HR, 0.87; 95% CI, 0.72-1.06). Use of time-dependent models showed a similar unadjusted association (HR, 0.62; 95% CI, 0.54-0.72), with the relationship remaining significant after adjustment for demographics and dialysis and CV risk factors (HR, 0.79; 95% CI, 0.66-0.94). Better memory was associated with lower mortality in univariate analysis (HR per 1 SD, 0.82; 95% CI, 0.69-0.96), but not when adjusting for demographics (HR, 1.00; 95% CI, 0.83-1.19). LIMITATIONS: Patients with dementia were excluded from the full battery, perhaps underestimating the strength of the association. CONCLUSIONS: Worse executive function and memory are associated with increased risk of mortality. For memory, this association is explained by patient demographics, whereas for executive function, this relationship may be explained in part by CV disease burden.
BACKGROUND:Cognitive impairment is common in hemodialysis patients and is associated with significant morbidity. Limited information exists about whether cognitive impairment is associated with survival and whether the type of cognitive impairment is important. STUDY DESIGN: Longitudinal cohort. SETTING & PARTICIPANTS: Cognitive function was assessed at baseline and yearly using a comprehensive battery of cognitive tests in 292 prevalent hemodialysis patients. PREDICTOR: Using principal component analysis, individual test results were reduced into 2 domain scores, representing memory and executive function. By definition, each score carried a mean of 0 and SD of 1. OUTCOMES: Association of each score with all-cause mortality was assessed using Cox proportional hazards models adjusted for demographics and dialysis and cardiovascular (CV) risk factors. RESULTS: Mean age of participants was 63 years, 53% were men, 23% were African American, and 90% had at least a high school education. During a median follow-up of 2.1 (IQR, 1.1-3.7) years, 145 deaths occurred. Each 1-SD better executive function score was associated with a 35% lower hazard of mortality (HR, 0.65; 95% CI, 0.55-0.76). In models adjusting for demographics and dialysis-related factors, this relationship was partially attenuated but remained significant (HR, 0.81; 95% CI, 0.67-0.98), whereas adjustment for CV disease and heart failure resulted in further attenuation (HR, 0.87; 95% CI, 0.72-1.06). Use of time-dependent models showed a similar unadjusted association (HR, 0.62; 95% CI, 0.54-0.72), with the relationship remaining significant after adjustment for demographics and dialysis and CV risk factors (HR, 0.79; 95% CI, 0.66-0.94). Better memory was associated with lower mortality in univariate analysis (HR per 1 SD, 0.82; 95% CI, 0.69-0.96), but not when adjusting for demographics (HR, 1.00; 95% CI, 0.83-1.19). LIMITATIONS: Patients with dementia were excluded from the full battery, perhaps underestimating the strength of the association. CONCLUSIONS: Worse executive function and memory are associated with increased risk of mortality. For memory, this association is explained by patient demographics, whereas for executive function, this relationship may be explained in part by CV disease burden.
Authors: Eric P Sorensen; Mark J Sarnak; Hocine Tighiouart; Tammy Scott; Lena M Giang; Bethany Kirkpatrick; Kristina Lou; Daniel E Weiner Journal: Am J Kidney Dis Date: 2012-03-15 Impact factor: 8.860
Authors: Daniel E Weiner; Tammy M Scott; Lena M Giang; Brian T Agganis; Eric P Sorensen; Hocine Tighiouart; Mark J Sarnak Journal: Am J Kidney Dis Date: 2011-07-20 Impact factor: 8.860
Authors: Konstadina Griva; Jan Stygall; Matthew Hankins; Andrew Davenport; Michael Harrison; Stanton P Newman Journal: Am J Kidney Dis Date: 2010-08-25 Impact factor: 8.860
Authors: Arema A Pereira; Daniel E Weiner; Tammy Scott; Priya Chandra; Robyn Bluestein; John Griffith; Mark J Sarnak Journal: Hemodial Int Date: 2007-07 Impact factor: 1.812
Authors: David A Drew; Rafeeque Bhadelia; Hocine Tighiouart; Vera Novak; Tammy M Scott; Kristina V Lou; Kamran Shaffi; Daniel E Weiner; Mark J Sarnak Journal: Am J Kidney Dis Date: 2012-10-03 Impact factor: 8.860
Authors: Mark Duncan Findlay; Jesse Dawson; David Alexander Dickie; Kirsten P Forbes; Deborah McGlynn; Terry Quinn; Patrick B Mark Journal: J Am Soc Nephrol Date: 2018-12-07 Impact factor: 10.121
Authors: Alvin G Thomas; Jessica M Ruck; Ashton A Shaffer; Christine E Haugen; Hao Ying; Fatima Warsame; Nadia Chu; Michelle C Carlson; Alden L Gross; Silas P Norman; Dorry L Segev; Mara McAdams-DeMarco Journal: Transplantation Date: 2019-07 Impact factor: 4.939
Authors: David A Drew; Hocine Tighiouart; Jasmine Rollins; Sarah Duncan; Seda Babroudi; Tammy Scott; Daniel E Weiner; Mark J Sarnak Journal: J Am Soc Nephrol Date: 2020-03-04 Impact factor: 10.121
Authors: Mara A McAdams-DeMarco; Matthew Daubresse; Sunjae Bae; Alden L Gross; Michelle C Carlson; Dorry L Segev Journal: Clin J Am Soc Nephrol Date: 2018-08-09 Impact factor: 8.237
Authors: Mara A McAdams-DeMarco; Sunjae Bae; Nadia Chu; Alden L Gross; Charles H Brown; Esther Oh; Paul Rosenberg; Karin J Neufeld; Ravi Varadhan; Marilyn Albert; Jeremy Walston; Dorry L Segev Journal: J Am Soc Nephrol Date: 2016-12-15 Impact factor: 10.121
Authors: Akhil Sharma; Jonathan Yabes; Saleem Al Mawed; Christine Wu; Carol Stilley; Mark Unruh; Manisha Jhamb Journal: Am J Nephrol Date: 2016-11-01 Impact factor: 3.754
Authors: David A Drew; Daniel E Weiner; Hocine Tighiouart; Sarah Duncan; Aditi Gupta; Tammy Scott; Mark J Sarnak Journal: Am J Kidney Dis Date: 2017-01-26 Impact factor: 8.860
Authors: Manjula Kurella Tamura; Eric Vittinghoff; Chi-Yuan Hsu; Karman Tam; Stephen L Seliger; Stephen Sozio; Michael Fischer; Jing Chen; Eva Lustigova; Louise Strauss; Rajat Deo; Alan S Go; Kristine Yaffe Journal: Kidney Int Date: 2017-01-27 Impact factor: 10.612
Authors: David A Drew; Hocine Tighiouart; Sarah Duncan; Jasmine Rollins; Aditi Gupta; Tammy Scott; Daniel E Weiner; Mark J Sarnak Journal: Am J Nephrol Date: 2019-05-02 Impact factor: 3.754